La Haute Autorit\u00e9 de sant\u00e9 (HAS) publie, le 6 ao\u00fbt 2026, une recommandation de bonne pratique en r\u00e9ponse \u00e0 une saisine du minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9 portant sur la mise en \u0153uvre de l\u2019article 54 de la loi de financement de la s\u00e9curit\u00e9 sociale (LFSS) pour 2026. Cet article pr\u00e9voit la cr\u00e9ation d\u2019un \u00ab parcours d\u2019accompagnement pr\u00e9ventif sur prescription m\u00e9dicale \u00bb (PAP) destin\u00e9 aux assur\u00e9s sociaux souffrant d\u2019une pathologie \u00e0 risque d\u2019\u00e9volution vers une affection de longue dur\u00e9e (ALD).<\/p>\n
L\u2019objectif principal de la recommandation est de d\u00e9finir les crit\u00e8res m\u00e9dicaux ouvrant droit \u00e0 la prise en charge dans le cadre de ce PAP. Celui-ci rel\u00e8ve \u00e0 la fois de la pr\u00e9vention primaire et secondaire, ce qui implique des crit\u00e8res d\u2019acc\u00e8s diff\u00e9renci\u00e9s selon le niveau de risque et le stade clinique des patients. La HAS distingue ainsi deux profils : d\u2019une part, les patients \u00e9ligibles \u00e0 un PAP de pr\u00e9vention primaire, car \u00e0 risque d\u2019\u00e9volution vers une maladie chronique et\/ou une ALD ; d\u2019autre part, les patients \u00e9ligibles \u00e0 un PAP de pr\u00e9vention secondaire, car durablement stabilis\u00e9s ou en r\u00e9mission document\u00e9e.<\/p>\n
Les publics prioritairement concern\u00e9s sont les patients atteints de pathologies cardiovasculaires et associ\u00e9es, et\/ou pr\u00e9sentant un risque neuro-cardiovasculaire, ainsi que les personnes vivant avec un diab\u00e8te sans complication m\u00e9dicale, une hypertension art\u00e9rielle et\/ou une ob\u00e9sit\u00e9. Sont \u00e9galement vis\u00e9s les patients d\u00e9j\u00e0 inclus dans certains dispositifs ALD : ALD 1 (accident vasculaire c\u00e9r\u00e9bral invalidant), ALD 3 (art\u00e9riopathies chroniques avec manifestations isch\u00e9miques), ALD 8 (diab\u00e8te de type 1 et diab\u00e8te de type 2), ALD 13 (maladie coronaire) et ALD 19 (n\u00e9phropathie chronique grave et syndrome n\u00e9phrotique primitif ou idiopathique). La note de cadrage associ\u00e9e pr\u00e9cise l\u2019articulation entre ce nouveau parcours d\u2019accompagnement pr\u00e9ventif et le dispositif existant des affections de longue dur\u00e9e.\u00a0(contenu r\u00e9sum\u00e9 par l’IA)\u200bLire la Suite<\/a>\u200b<\/p>","protected":false},"excerpt":{"rendered":" La Haute Autorit\u00e9 de sant\u00e9 (HAS) publie, le 6 ao\u00fbt 2026, une recommandation de bonne pratique en r\u00e9ponse \u00e0 une saisine du minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9 portant […]<\/p>\n","protected":false},"author":1,"featured_media":4149,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[7,4],"tags":[66,227],"class_list":["post-14968","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicaments-et-produits-de-sante","category-offre-de-soins-et-hopital","tag-has","tag-ia"],"_links":{"self":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/14968","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=14968"}],"version-history":[{"count":0,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/14968\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/media\/4149"}],"wp:attachment":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=14968"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=14968"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=14968"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}